Photo used for illustrative purpose.
AstraZeneca also revealed in other findings that its preventative moniclonal antibody treatment, Evusheld, "retains neutralisation activity" against Omicron.
The threat of the highly transmissible Omicron variant looms large over the festive holidays, forcing many governments to roll out new curbs and urge citizens to get vaccinated.
"Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose booster," AstraZeneca said in a statement.
"The third dose booster vaccination neutralised the Omicron variant to levels that were broadly similar to those observed... after the second dose against the Delta variant."
Levels of neutralising antibodies were also higher with the booster jab than with individuals who had previously been infected and recovered naturally.
Boosters 'limit Omicron spread'
The study was conducted by investigators from the University of Oxford, which is the academic institution which helped AstraZeneca develop the vaccine last year.
Researchers analysed blood samples taken from individuals infected with COVID-19; those vaccinated with two doses plus a booster; and those who had reported previous infection.
"It is very encouraging to see that current vaccines have the potential to protect against Omicron following a third dose booster," said University of Oxford professor John Bell, one of the study investigators. "These results support the use of third dose boosters as part of national vaccine strategies, especially to limit the spread of variants of concern, including Omicron."
Mene Pangalos, AstraZeneca's executive vice-president of biopharmaceuticals research and development, said that the study should boost confidence in the extra jab.
"Vaxzevria plays an important role in vaccination programmes around the world and these data give us confidence that the vaccine should be given as a third dose booster," said Pangalos.
"It is also important to look beyond antibodies to better understand how vaccines offer protection against Omicron. "As we better understand Omicron, we believe we will find that T-cell response provides durable protection against severe disease and hospitalisations."
In a recent survey, people who said social distancing and COVID-safety guidelines violated their personal freedoms responded more positively to these ideas when they felt a loved one might be at risk of severe illness.
The new US study will include up to 1,420 volunteers ages 18 to 55 to test the updated Omicron-based shots for use as a booster or for primary vaccinations. Researchers will examine the tweaked vaccine’s safety and how it revs up the immune system...
The European Medicines Agency's human medicines committee "has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years of age."
"At a time where the Omicron variant is rapidly spreading, and where we need to step up vaccination and the administration of boosters, I am particularly pleased with today's authorisation of the Novavax vaccine," said EU chief Ursula von der Leyen.
In the main store in China, which is located in the center of the capital, Beijing, thousands lined up on Friday morning to obtain the latest iPhone, despite market fears that nationalist enthusiasm would weaken the American company’s sales in China.
These accidents led to the tragic loss of three lives, with 75 individuals sustaining varied injuries: two with severe injuries, 44 with moderate injuries, and 29 with minor ones.
These activities are part of the ongoing preparations for the "Union Fortress 9" military parade, scheduled to take place in November in Abu Dhabi.
The deployment of the team, the first of its kind in the world to be in Derna following the natural disaster that hit the country recently, comes as part of the UAE's efforts to aid Libya in dealing with the aftermath of the floods caused by the heavy rains, resulting in thousands of deaths and injuries.